BridgeMD
New treatment option for Stroke
Official title Virtual Reality for Post-Stroke Gait Rehabilitation
ClinicalTrials.gov ID: NCT07201974
What this study is testing
- What it's testing
- The goal of this clinical trial is to: (1) implement and test the feasibility of a new VR-ODT intervention offered as part of usual therapy time of patients with a sub-acute stoke; (2) explore the acceptability of the intervention from the perspective of clinicians and patients and; (3) implement measures to optimize the uptake and sustainability of the intervention within the clinical setting. Participants will engage in a personalized VR-ODT training for 4 weeks (2X 1hr/week) targeting six well-established community walking demands related to (1) walking speed and (2) distance; (3) postural transitions; (4) obstacle avoidance; (5) dual-task walking and; (6) a combination of demands 1-5.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 84
You may be able to join if
- Eligible patients with stroke referred by clinicians of the inpatient and outpatient stroke rehabilitation programs at the Jewish Rehabilitation...
- be aged between 40 and 74 years;
- have normal/corrected visual and auditory acuity present;
- present a first-ever supratentorial unilateral stroke of 1-24 weeks duration;
- present the ability to walk independently with/without walking aids for at least 1 min at a speed of 0.4-0.9 m/s;
You likely can't join if
- people with comorbidities interfering with walking
- people with comorbidities interfering with visual perception
- people without medical clearance for exercise
See the full eligibility criteria
- Eligible patients with stroke referred by clinicians of the inpatient and outpatient stroke rehabilitation programs at the Jewish Rehabilitation Hospital (CISSS Laval) for mobility problems over a period of 6 months...
- be aged between 40 and 74 years;
- have normal/corrected visual and auditory acuity present;
- present a first-ever supratentorial unilateral stroke of 1-24 weeks duration;
- present the ability to walk independently with/without walking aids for at least 1 min at a speed of 0.4-0.9 m/s;
- present intact or mildly affected cognitive function (MoCA scores ≥ 22/30);
- present intact to moderately affected visual- perceptual function (positive scores on a max. of 3/6 tasks on the Behavioural Inattention Test).
- people with comorbidities interfering with walking
- people with comorbidities interfering with visual perception
- people without medical clearance for exercise
The study team makes the final eligibility decision.
Where it's taking place
- Laval, Quebec, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 84 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Laval, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.